Further processing options
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery fro...
Saved in:
Journal Title: | OncoTargets and Therapy |
---|---|
Authors and Corporations: | , , , , |
In: | OncoTargets and Therapy, Volume 12, 2019, p. 5545-5549 |
Type of Resource: | E-Article |
Language: | English |
published: |
Informa UK Limited
|
Subjects: |